Jefferies Financial Group Inc. (JEF)

NYSE: JEF · Real-Time Price · USD
59.57
+0.52 (0.89%)
Dec 9, 2025, 4:00 PM EST - Market closed
0.89%
Market Cap12.29B
Revenue (ttm)7.23B
Net Income (ttm)646.47M
Shares Out 206.28M
EPS (ttm)2.92
PE Ratio20.51
Forward PE14.77
Dividend$1.60 (2.67%)
Ex-Dividend DateNov 17, 2025
Volume1,854,276
Open59.50
Previous Close59.04
Day's Range59.50 - 61.04
52-Week Range39.28 - 82.68
Beta1.50
AnalystsBuy
Price Target72.00 (+20.85%)
Earnings DateJan 7, 2026

About JEF

Jefferies Financial Group Inc. operates as an investment banking and capital markets firm in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Investment Banking and Capital Markets, and Asset Management. It provides investment banking, advisory services with respect to mergers or acquisitions, debt financing, restructurings or recapitalizations, and private capital advisory transactions; underwriting and placement services related to corporate debt, municipal debts, mortgage-backed and asset-bac... [Read more]

Sector Financials
Founded 1968
Employees 7,822
Stock Exchange NYSE
Ticker Symbol JEF
Full Company Profile

Financial Performance

In 2024, Jefferies Financial Group's revenue was $7.01 billion, an increase of 49.15% compared to the previous year's $4.70 billion. Earnings were $669.27 million, an increase of 156.48%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for JEF stock is "Buy." The 12-month stock price target is $72.0, which is an increase of 20.85% from the latest price.

Price Target
$72.0
(20.85% upside)
Analyst Consensus: Buy
Stock Forecasts

News

JEF INVESTIGATION: Jefferies Financial Group Inc. Securities Fraud Investigation is Pending, Investors Notified to Contact BFA Law

New York, New York--(Newsfile Corp. - December 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bo...

1 day ago - Newsfile Corp

Jefferies to Acquire 50% Interest in Hildene Holding Company, Expanding Strategic Relationship that Began in 2022

NEW YORK--(BUSINESS WIRE)--Jefferies Financial Group Inc. (NYSE: JEF) (“Jefferies”) announced today it is acquiring a 50% interest in Hildene Holding Company, LLC, the parent of Hildene Capital Manage...

1 day ago - Business Wire

JEF INVESTOR LOSSES: Lose Money on Jefferies Financial Group Inc.? Contact BFA Law about its Securities Fraud Investigation

NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital f...

2 days ago - GlobeNewsWire

Jefferies Financial Group Inc. (JEF) Investors that Lost Money are Encouraged to Act – Contact BFA Law about its Pending Securities Fraud Investigation

Jefferies Financial Group Inc. (JEF) Investors that Lost Money are Encouraged to Act – Contact BFA Law about its Pending Securities Fraud Investigation

4 days ago - GlobeNewsWire

JEF NEWS: Jefferies Financial Group Inc. Investigated for Securities Fraud after Stock Plummets 8% -- Investors Notified to Contact BFA Law

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

6 days ago - GlobeNewsWire

JEF INVESTORS: Jefferies Financial Group Inc. Investors are Notified to Contact BFA Law about its Ongoing Investigation after SEC Probe into Point Bonita Disclosures

New York, New York--(Newsfile Corp. - December 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bo...

8 days ago - Newsfile Corp

JEF SHAREHOLDERS: The SEC is Probing Jefferies Financial Group Inc. over its Point Bonita Disclosures – Investors Notified to Contact BFA Law about its Ongoing Investigation

The SEC is Probing Jefferies Financial Group Inc. over its Point Bonita Disclosures – Investors Notified to Contact BFA Law about its Ongoing Investigation

8 days ago - GlobeNewsWire

JEF INVESTIGATION NOTICE: BFA Law is Investigating Jefferies Financial Group Inc. for Securities Fraud After SEC Probe into Point Bonita Disclosures

New York, New York--(Newsfile Corp. - November 30, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...

9 days ago - Newsfile Corp

JEF SEC PROBE: Jefferies Financial Group Inc. is Facing a Probe by the SEC Over its Point Bonita Disclosures – Contact BFA Law if You Lost Money on Your Investment

Jefferies Financial Group Inc. is Facing a Probe by the SEC Over its Point Bonita Disclosures – Contact BFA Law if You Lost Money on Your Investment

10 days ago - GlobeNewsWire

JEF SEC NEWS: SEC Probe into Jefferies Financial Group Inc. Revealed Over Point Bonita Disclosures, Investors Notified to Contact BFA Law

New York, New York--(Newsfile Corp. - November 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...

11 days ago - Newsfile Corp

JEF BREAKING: SEC Probe into Jefferies Financial Group Inc. Revealed Over its Point Bonita Disclosures – Investors with Losses Alerted to Contact BFA Law

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

12 days ago - GlobeNewsWire

SEC investigates Jefferies over First Brands collapse, report says

The newspaper, citing people with knowledge of the matter, said the regulator is looking into whether Jefferies gave investors enough information on its Point Bonita fund's exposure to the failed auto...

12 days ago - CNBC

JEF BREAKING NEWS: Jefferies Financial Group Inc. Faces SEC Probe Over Point Bonita Disclosures – Investors Urged to Contact BFA Law about its Investigation

NEW YORK--(BUSINESS WIRE)---- $JEF #BFA--Jefferies Financial Group Inc. Faces SEC Probe Over Point Bonita Disclosures – Investors Urged to Contact BFA Law about its Investigation.

12 days ago - Business Wire

JEFFERIES NOTICE: Jefferies Financial Group Inc. (JEF) Faces Securities Fraud Investigation after Stock Drops 8%, Investors Urged to Contact BFA Law

New York, New York--(Newsfile Corp. - November 24, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...

15 days ago - Newsfile Corp

JEF SHAREHOLDERS: A Securities Investigation into Jefferies Financial Group Inc. has been Initiated on behalf of Investors -- Contact BFA Law if You Suffered Losses

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

18 days ago - GlobeNewsWire

Court orders independent probe into First Brands fraud allegations

A U.S. bankruptcy judge on Wednesday ordered an independent investigation into auto parts maker First Brands, allocating a $7 million budget to probe allegations of fraud involving the company's use o...

Other symbols: UBS
19 days ago - Reuters

JEF STOCK: Jefferies Financial Group Inc. Investigated for Securities Fraud after 8% Stock Drop -- Investors Notified to Contact BFA Law

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

20 days ago - GlobeNewsWire

Saga Diagnostics to Present at Jefferies Global Healthcare Conference in London

MORRISVILLE, N.C.--(BUSINESS WIRE)-- #JefferiesHealthcare--Presentation will focus on its flagship MRD assay, Pathlight, accompanied by a commercial update following its favorable Medicare coverage.

21 days ago - Business Wire

Vicore to Present at The Jefferies Global Healthcare Conference in London

STOCKHOLM, SE / ACCESS Newswire / November 17, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), t...

22 days ago - Accesswire

JEFFERIES INVESTORS: Jefferies Financial Group Inc. (JEF) is being Investigated for Securities Fraud, Investors are Urged to Contact BFA Law

New York, New York--(Newsfile Corp. - November 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...

25 days ago - Newsfile Corp

Medincell Management to Participate in Fireside Chat at the Jefferies London Healthcare Conference 2025 (London - Nov. 17-20, 2025)

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Christophe Douat, Chief Executive Officer, and Dr. Richard Malamut, Chief Medical Officer, will present Medincell's (Paris:MEDCL) corporate overv...

26 days ago - Business Wire

Keenova to Participate in the Jefferies Global Healthcare Conference in London

DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London on Wed...

27 days ago - PRNewsWire

Beacon Therapeutics to Participate in the Jefferies Global Healthcare Conference

LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics' or ‘the Company'), a leading clinical-stage biotechnology company with a miss...

27 days ago - GlobeNewsWire

AdvanCell to participate in Jefferies Global Healthcare Conference in London

SYDNEY--(BUSINESS WIRE)-- #JefferiesGlobalHealthcareConference--AdvanCell to share positive 212Pb-ADVC001 results and US expansion updates at the Jefferies Global Healthcare Conference in London (17–2...

4 weeks ago - Business Wire

Aqemia to Participate in the Jefferies Global Healthcare Conference 2025

LONDON--(BUSINESS WIRE)--Aqemia, a pioneering TechBio company combining generative AI and quantum-inspired physics to invent drugs, announces that Maximilien Levesque, CEO and co-founder, and Théa Vu-...

4 weeks ago - Business Wire